A carregar...

Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma

INTRODUCTION: Prior studies have demonstrated an increased risk of cancer-associated scleroderma in patients with RNA polymerase III (POL) autoantibodies and in patients negative for anti-centromere (CENP), anti-topoisomerase-1 (TOPO), and anti-POL antibodies (referred to as CENP/TOPO/POL (CTP)-Nega...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Shah, Ami A., Xu, George, Rosen, Antony, Hummers, Laura K., Wigley, Fredrick M., Elledge, Stephen J., Casciola-Rosen, Livia
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5449218/
https://ncbi.nlm.nih.gov/pubmed/28217959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!